Literature DB >> 28785179

How to Achieve Optimal Care in Early Breast Cancer with 'Less' or 'More' Treatment.

Giuseppe Curigliano1.   

Abstract

Entities:  

Year:  2017        PMID： 28785179      PMCID： PMC5527166          DOI： 10.1159/000478652

Source DB:  PubMed          Journal:  Breast Care (Basel)        ISSN： 1661-3791            Impact factor:   2.860


× No keyword cloud information.
  9 in total

1.  Identifying clinically relevant prognostic subgroups of postmenopausal women with node-positive hormone receptor-positive early-stage breast cancer treated with endocrine therapy: a combined analysis of ABCSG-8 and ATAC using the PAM50 risk of recurrence score and intrinsic subtype.

Authors:  M Gnant; I Sestak; M Filipits; M Dowsett; M Balic; E Lopez-Knowles; R Greil; P Dubsky; H Stoeger; M Rudas; R Jakesz; S Ferree; J W Cowens; T Nielsen; C Schaper; C Fesl; J Cuzick
Journal:  Ann Oncol       Date:  2015-05-01       Impact factor: 32.976

2.  West German Study Group Phase III PlanB Trial: First Prospective Outcome Data for the 21-Gene Recurrence Score Assay and Concordance of Prognostic Markers by Central and Local Pathology Assessment.

Authors:  Oleg Gluz; Ulrike A Nitz; Matthias Christgen; Ronald E Kates; Steven Shak; Michael Clemens; Stefan Kraemer; Bahriye Aktas; Sherko Kuemmel; Toralf Reimer; Manfred Kusche; Volker Heyl; Fatemeh Lorenz-Salehi; Marianne Just; Daniel Hofmann; Tom Degenhardt; Cornelia Liedtke; Christer Svedman; Rachel Wuerstlein; Hans H Kreipe; Nadia Harbeck
Journal:  J Clin Oncol       Date:  2016-02-29       Impact factor: 44.544

3.  A new molecular predictor of distant recurrence in ER-positive, HER2-negative breast cancer adds independent information to conventional clinical risk factors.

Authors:  Martin Filipits; Margaretha Rudas; Raimund Jakesz; Peter Dubsky; Florian Fitzal; Christian F Singer; Otto Dietze; Richard Greil; Andrea Jelen; Paul Sevelda; Christa Freibauer; Volkmar Müller; Fritz Jänicke; Marcus Schmidt; Heinz Kölbl; Achim Rody; Manfred Kaufmann; Werner Schroth; Hiltrud Brauch; Matthias Schwab; Peter Fritz; Karsten E Weber; Inke S Feder; Guido Hennig; Ralf Kronenwett; Mathias Gehrmann; Michael Gnant
Journal:  Clin Cancer Res       Date:  2011-08-01       Impact factor: 12.531

Review 4.  Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline.

Authors:  Lyndsay N Harris; Nofisat Ismaila; Lisa M McShane; Fabrice Andre; Deborah E Collyar; Ana M Gonzalez-Angulo; Elizabeth H Hammond; Nicole M Kuderer; Minetta C Liu; Robert G Mennel; Catherine Van Poznak; Robert C Bast; Daniel F Hayes
Journal:  J Clin Oncol       Date:  2016-02-08       Impact factor: 44.544

5.  70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer.

Authors:  Fatima Cardoso; Laura J van't Veer; Jan Bogaerts; Leen Slaets; Giuseppe Viale; Suzette Delaloge; Jean-Yves Pierga; Etienne Brain; Sylvain Causeret; Mauro DeLorenzi; Annuska M Glas; Vassilis Golfinopoulos; Theodora Goulioti; Susan Knox; Erika Matos; Bart Meulemans; Peter A Neijenhuis; Ulrike Nitz; Rodolfo Passalacqua; Peter Ravdin; Isabel T Rubio; Mahasti Saghatchian; Tineke J Smilde; Christos Sotiriou; Lisette Stork; Carolyn Straehle; Geraldine Thomas; Alastair M Thompson; Jacobus M van der Hoeven; Peter Vuylsteke; René Bernards; Konstantinos Tryfonidis; Emiel Rutgers; Martine Piccart
Journal:  N Engl J Med       Date:  2016-08-25       Impact factor: 91.245

6.  Prospective Validation of a 21-Gene Expression Assay in Breast Cancer.

Authors:  Joseph A Sparano; Robert J Gray; Della F Makower; Kathleen I Pritchard; Kathy S Albain; Daniel F Hayes; Charles E Geyer; Elizabeth C Dees; Edith A Perez; John A Olson; JoAnne Zujewski; Tracy Lively; Sunil S Badve; Thomas J Saphner; Lynne I Wagner; Timothy J Whelan; Matthew J Ellis; Soonmyung Paik; William C Wood; Peter Ravdin; Maccon M Keane; Henry L Gomez Moreno; Pavan S Reddy; Timothy F Goggins; Ingrid A Mayer; Adam M Brufsky; Deborah L Toppmeyer; Virginia G Kaklamani; James N Atkins; Jeffrey L Berenberg; George W Sledge
Journal:  N Engl J Med       Date:  2015-09-27       Impact factor: 91.245

7.  Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone.

Authors:  M Gnant; M Filipits; R Greil; H Stoeger; M Rudas; Z Bago-Horvath; B Mlineritsch; W Kwasny; M Knauer; C Singer; R Jakesz; P Dubsky; F Fitzal; R Bartsch; G Steger; M Balic; S Ressler; J W Cowens; J Storhoff; S Ferree; C Schaper; S Liu; C Fesl; T O Nielsen
Journal:  Ann Oncol       Date:  2013-12-16       Impact factor: 32.976

8.  The EndoPredict score provides prognostic information on late distant metastases in ER+/HER2- breast cancer patients.

Authors:  P Dubsky; J C Brase; R Jakesz; M Rudas; C F Singer; R Greil; O Dietze; I Luisser; E Klug; R Sedivy; M Bachner; D Mayr; M Schmidt; M C Gehrmann; C Petry; K E Weber; K Fisch; R Kronenwett; M Gnant; M Filipits
Journal:  Br J Cancer       Date:  2013-10-24       Impact factor: 7.640

9.  Prediction of late distant recurrence in patients with oestrogen-receptor-positive breast cancer: a prospective comparison of the breast-cancer index (BCI) assay, 21-gene recurrence score, and IHC4 in the TransATAC study population.

Authors:  Dennis C Sgroi; Ivana Sestak; Jack Cuzick; Yi Zhang; Catherine A Schnabel; Brock Schroeder; Mark G Erlander; Anita Dunbier; Kally Sidhu; Elena Lopez-Knowles; Paul E Goss; Mitch Dowsett
Journal:  Lancet Oncol       Date:  2013-09-12       Impact factor: 41.316
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.